Eurofins BioPharma Product Testing (US) Revenue and Competitors

Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world's largest pharmaceutical, biopharmaceutical and medical device companies. Our service offerings are fully comprehensive and include testing of drug substance, final product, intermediates, and starting materials for both small and large molecule drug products. We give clients the flexibility to choose from three service models to meet specific project needs, including the award-winning Professional Scientific Services® (PSS) and we also provide secure 24-hour data access via our online data portal, LabAccess.com. Our laboratories offer a broad range of methodologies under GMP authorization, ISO 17025 accreditation and ISO 9000 certification and all analysis are performed according to European and British Pharmacopeia (EP and BP), United States Pharmacopeia (USP) and Japanese Pharmacopeia (JP), as well as specific customer methods. With a global capacity of more than 159,000 square meters and facilities located in Australia, Belgium, Canada, Denmark, France, Germany, India, Ireland, Italy, Japan, Netherlands, New Zealand, Spain, Sweden, Switzerland, UK and the US, our network of GMP laboratories operates under the same strict quality procedures, LIMS and centralized billing system across 35 locations worldwide. Our local presence with four key sites in the US, including Lancaster, PA; Portage, MI; Columbia, MO; and San Diego, CA, ensures personal service backed by a unique global breadth of harmonized capabilities that supports all functional areas of bio/pharmaceutical drug development.